Live Cell Imaging Market Research Report – Forecast to 2027

Live Cell Imaging Market Research Report: Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User- Forecast Till 2027

ID: MRFR/MED/4617-HCR | February 2021 | Region: Global | 100 pages

Live Cell Imaging Market Scenario


The live cell imaging market is expected to gain prominence over the forecast period. It is estimated that the global live cell imaging market is expected to grow at a CAGR ~9.0 % With USD 8.5 Billion By 2027.

Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, the adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the live cell imaging global market.

However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period.

The live cell imaging global market is currently dominated by many players. For instance, in April 2016, BioTek Instruments launched Lionheart FX, an automated live cell imager with augmented microscopy. Moreover, the company announced the collaboration with MilliporeSigma for long-term dynamic time-lapse analyses and live cell experiments. This collaboration involved the development of an integrated solution comprising MilliporeSigma's CellASIC ONIX2 Microfluidic system and BioTek's Lionheart FX Automated Live Cell Imager. 

 

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the live cell imaging market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.


  • Primary Research


The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the live cell imaging market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global live cell imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the live cell imaging market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Live Cell Imaging Market Key Players


Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.) are some prominent players in this live cell imaging market.

Segmentation


The global live cell imaging market is segmented on the basis of the product, technology, application, and end-user.

On the basis of product, the market is classified as equipment, consumables, and software. The equipment is further segmented as microscopes, standalone systems, cell analyzer, and image-capturing devices. The microscopes are further sub-segmented as conventional microscopes, confocal microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented as assay kits, reagents, media, and others.

The live cell imaging global market on the basis of technology is segmented as fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high-content analysis, ratiometric imaging, fluorescence in situ hybridization, total internal reflection fluorescence microscopy, multiphoton excitation microscopy and other technologies.

On the basis of application, the market is segmented into cell biology, stem cells, developmental biology, and drug discovery.

On the basis of end-user, the market is segmented as pharmaceutical companies, biotechnology companies, hospitals, diagnostic laboratories, and others.

Geographically, the global live cell imaging market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American live cell imaging market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The Europe live cell imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and Rest of Western Europe.

The Asia Pacific live cell imaging market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle East & Africa live cell imaging market is segmented into the Middle East and Africa.

Regional Market Summary

Global Live Cell Imaging Market, by Region Market Share, 2017 (%)


 Live Cell Imaging Market


Source: MRFR Analysis


The American region holds the major share of the global live cell imaging makret, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, and technological advancements. According to the report published by the American Cancer Society, 2017, around 190,500 of the estimated 600,920 cancer deaths in the United States are likely to be caused owing to cigarette smoking. Moreover, factors such as high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality fuel the market growth in this region.

Europe holds the second position in the global live cell imaging market. It is expected that government support towards research & development expenditure and rising prevalence chronic diseases are likely to drive the European live cell imaging market. In addition, the presence of some key players such as Carl Zeiss AG,  Leica Microsystems, and GE Healthcare in this region also facilitates the growth of this market. For instance, in November 2016, Carl Zeiss AG launched ZEISS celldiscover 7 automated microscope for live cell imaging. With this launch, the company expanded its product portfolio in live cell imaging.

The Asia Pacific live cell imaging market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for live cell imaging due to an increase in the prevalence of cancer and demand for live cell imaging techniques. In China, factors responsible for the market growth are rising geriatric population with chronic diseases and availability of low-cost diagnostic and treatment options.

The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Live Cell Imaging Market, by Product



  • Equipment

  • Microscopes

  • Conventional Microscopes

  • Confocal Microscopes

  • Advanced Fluorescence Microscopes

  • Standalone Systems

  • Cell Analyzers

  • Image-capturing Devices

  • Consumables

  • Assay Kits

  • Reagents

  • Media

  • Others

  • Software


Live Cell Imaging Market, by Technology



  • Fluorescence Recovery After Photobleaching (FRAP)

  • Fluorescence Resonance Energy Transfer (FRET)

  • High-content Analysis

  • Ratiometric Imaging

  • Fluorescence In Situ Hybridization (FISH)

  • Total Internal Reflection Fluorescence Microscopy (TRIF)

  • Multiphoton Excitation Microscopy (MPE)

  • Others


Live Cell Imaging Market, by Application



  • Cell Biology

  • Stem Cells

  • Developmental Biology

  • Drug Discovery


Live Cell Imaging Market, by End-user



  • Pharmaceutical Companies

  • Biotechnological Companies

  • Hospitals

  • Diagnostic Laboratories

  • Others


Live Cell Imaging Market, by Region



  • North America


    • US

    • Canada


  • Europe


    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe


  • Asia-Pacific


    • China


      • Japan

      • India

      • Australia

      • South Korea

      • Rest of Asia-Pacific



  • Rest of the World


    • Middle East

    • Africa

    • Latin America



Company Profiles    



  • Carl Zeiss AG

  • Leica Microsystems

  • Nikon Corporation

  • Molecular Devices, LCC

  • PerkinElmer, Inc.

  • GE Healthcare

  • Becton, Dickinson, and Company

  • Olympus Corporation

  • Sigma-Aldrich Corporation

  • Thermo Fischer Scientific, Inc.

  • Danaher Corporation

  • BioTek Instruments


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 8.5 Billiion
  CAGR   2020-2027: ~9%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Technology, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.)
  Key Market Opportunities   Adoption of high content screening techniques in drug discovery and cell biology
  Key Market Drivers

  • Increasing prevalence of chronic diseases
  • Growing government funding in cell-based research


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Lack of technical expertise and high cost of screening systems can prohibit the live cell imaging market from achieving expected growth.

    Japan has the upper hand in the Asia Pacific live cell imaging market.

    The North American live cell imaging market would get boosted by better research and development facilities, and a hike in investment plans for the market.

    The live cell imaging market would be bolstered by industries like biotechnology companies, pharmaceutical companies, diagnostic laboratories, hospitals, and others.

    The live cell imaging market would record a CAGR of 9% during the forecast period of 2020 to 2027.

    Table Of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Live Cell Imaging Market, By Product

    6.1 Introduction

    6.2 Equipment

    6.2.1 Microscopes

    6.2.1.1 Conventional Microscopes

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.2.1.2 Confocal Microscopes

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.2.1.3 Advanced Fluorescence Microscopes

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.2.2 Standalone Systems

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.2.3 Cell Analyzers

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.2.4 Image-Capturing Devices

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3 Consumables

    6.3.1 Assay Kits

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3.2 Reagents

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3.3 Media

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3.4 Others

    6.4 Software

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    Chapter 7. Global Live Cell Imaging Market, By Technology

    7.1 Introduction

    7.2 Fluorescence Recovery After Photobleaching (FRAP)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.3 Fluorescence Resonance Energy Transfer (FRET)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.4 High-Content Analysis (HCA)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.5 Ratiometric Imaging

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.6 Fluorescence In Situ Hydridization (FISH)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.7 Total Internal Reflection Fluorescence Microscopy (TRIF)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.8 Multiphoton Excitation Microscopy (MPE)

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.9 Others

    Chapter 8. Global Live Cell Imaging Market, By Application

    8.1 Introduction

    8.2 Cell Biology

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.3 Stem Cells

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.4 Developmental Biology

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.4 Drug Discovery

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    Chapter 9. Global Live Cell Imaging Market, By End-User

    9.1 Introduction

    9.2 Pharmaceutical Companies

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.3 Biotechnological Companies

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.4 Hospitals

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.5 Diagnostic Laboratories

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9.6 Others

    Chapter 10. Global Live Cell Imaging Market, By Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 U.K.

    10.3.1.6 Rest Of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic Of Korea

    10.4.6 Rest Of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 The Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Carl Zeiss AG

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Leica Microsystems

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Nikon Corporation

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Molecular Devices, LCC

    12.4.1 Company Overview

    12.4.2 Technology/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 PerkinElmer, Inc.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial Overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 GE Healthcare

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Becton, Dickinson And Company

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Olympus Corporation

    12.8.1 Overview

    12.8.2 Product/ Technology Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Sigma-Aldrich Corporation

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Thermo Fischer Scientific, Inc.

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Danaher Corporation

    12.11.1 Overview

    12.11.2 Product Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    12.12 BioTek Instruments

    12.12.1 Overview

    12.12.2 Product Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs Of The Market

    13.2 Key Companies To Watch

    13.3 Prediction Of The Arthroscopy Instruments Industry

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Global Live Cell Imaging Market Synopsis, 2020–2027

    Table 2 Global Live Cell Imaging Market Estimates And Forecast, 2020–2027, (USD Million)

    Table 3 Global Live Cell Imaging Market, By Region, 2020–2027, (USD Million)

    Table 4 Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 5 Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 6 Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 7 Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 8 North America Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 9 North America Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 10 North America Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 11 North America Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 12 U.S. Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 13 U.S. Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 14 U.S. Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 15 U.S. Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 16 Canada Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 17 Canada Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 18 Canada Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 19 Canada Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 20 South America Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 21 South America Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 22 South America Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 22 South America Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 23 Europe Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 24 Europe Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 25 Europe Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 26 Europe Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 27 Western Europe Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 28 Western Europe Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 29 Western Europe Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 30 Western Europe Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 31 Eastern Europe Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 32 Eastern Europe Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 33 Eastern Europe Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 34 Eastern Europe Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 35 Asia Pacific Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 36 Asia Pacific Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 37 Asia Pacific Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 38 Asia Pacific Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    Table 39 Middle East & Africa Global Live Cell Imaging Market, By Product, 2020–2027, (USD Million)

    Table 40 Middle East & Africa Global Live Cell Imaging Market, By Technology, 2020–2027, (USD Million)

    Table 41 Middle East & Africa Global Live Cell Imaging Market, By Application, 2020–2027, (USD Million)

    Table 42 Middle East & Africa Global Live Cell Imaging Market, By End-User, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Global Live Cell Imaging Market

    Figure 3 Segmentation Market Dynamics For Global Live Cell Imaging Market

    Figure 4 Global Live Cell Imaging Market Share, By Product, 2020

    Figure 5 Global Live Cell Imaging Market Share, By Technology, 2020

    Figure 6 Global Live Cell Imaging Market Share, By Application, 2020

    Figure 7 Global Live Cell Imaging Market Share, By Region, 2020

    Figure 8 North America Global Live Cell Imaging Market Share, By Country, 2020

    Figure 9 Europe Global Live Cell Imaging Market Share, By Country, 2020

    Figure 10 Asia Pacific Global Live Cell Imaging Market Share, By Country, 2020

    Figure 11 Middle East & Africa Global Live Cell Imaging Market Share, By Country, 2020

    Figure 12 Global Live Cell Imaging Market: Company Share Analysis, 2020 (%)

    Figure 13 Carl Zeiss AG: Key Financials

    Figure 15 Carl Zeiss AG: Segmental Revenue

    Figure 16 Carl Zeiss AG: Geographical Revenue

    Figure 17 Leica Microsystems: Key Financials

    Figure 18 Leica Microsystems: Segmental Revenue

    Figure 19 Leica Microsystems: Geographical Revenue

    Figure 20 Nikon Corporation: Key Financials

    Figure 21 Nikon Corporation: Segmental Revenue

    Figure 22 Nikon Corporation: Geographical Revenue

    Figure 23 Molecular Devices, LLC: Key Financials

    Figure 24 Molecular Devices, LLC: Segmental Revenue

    Figure 25 Molecular Devices, LLC: Geographical Revenue

    Figure 26 PerkinElmer, Inc.: Key Financials

    Figure 27 PerkinElmer, Inc.: Segmental Revenue

    Figure 28 PerkinElmer, Inc.: Geographical Revenue

    Figure 29 GE Healthcare: Key Financials

    Figure 30 GE Healthcare: Segmental Revenue

    Figure 31 GE Healthcare: Geographical Revenue

    Figure 32 Becton, Dickinson And Company: Key Financials

    Figure 33 Becton, Dickinson And Company: Segmental Revenue

    Figure 34 Becton, Dickinson And Company: Geographical Revenue

    Figure 35 Olympus Corporation: Key Financials

    Figure 36 Olympus Corporation: Segmental Revenue

    Figure 37 Olympus Corporation: Geographical Revenue

    Figure 38 Sigma-Aldrich Corporation: Key Financials

    Figure 39 Sigma-Aldrich Corporation: Segmental Revenue

    Figure 40 Sigma-Aldrich Corporation: Geographical Revenue

    Figure 41 Thermo Fischer Scientific, Inc.: Key Financials

    Figure 42 Thermo Fischer Scientific, Inc.: Segmental Revenue

    Figure 43 Thermo Fischer Scientific, Inc.: Geographical Revenue

    Figure 44 Danaher Corporation: Key Financials

    Figure 45 Danaher Corporation: Segmental Revenue

    Figure 46 Danaher Corporation: Geographical Revenue

    Figure 47 BioTek Instruments: Key Financials

    Figure 48 BioTek Instruments: Segmental Revenue

    Figure 49 BioTek Instruments: Geographical Revenue